Dew, how do you see this news affecting the approvability of DX-88. Looks like a vote of no confidence. Alternatively, it could be a strategic decision for GENZ (too many trials, for too long, for not too much money).
Also, this news makes the recent runup even more confusing.
DYAX is down only 4%. CEO Henry Blair evidently did a good job of spinning the GENZ pullout as non-negative. DYAX is even trading above the $3.86 valuation implicit in the DX-88 settlement.
Blair says clearing the decks of any GENZ influence may allow another company to bid for DX-88 in both HAE and CABG. I have my doubts that anyone will be interested.
News 
Market Data 
Discover 
AI
